Skip to main content
Fig. 3 | Cardiovascular Diabetology – Endocrinology Reports

Fig. 3

From: DPP4 inhibitors and COVID19 outcomes in patients with type II diabetes: a multicenter retrospective cohort study in Saudi Arabia

Fig. 3

Love’s plot of the covariate balance

Covariates balance are achieved by Covariate balance was achieved via the overlap weights methodology according to Li (2017) by weighting each unit proportional to its probability of assignment to the opposite group. The estimand is referred to “ATO” (average treatment effect in the overlap). SMD closer to zero are indicative of good balance. These computations were performed using the WeightIt package. Covariates balance diagnostics are assessed using the cobalt package in R

Abbreviations: WHO: World Health Organization; COVID-19: coronavirus disease 2019; HbA1c: hemoglobin A1c; SGLT-2i: Sodium-glucose transport protein-2 inhibitor; GLP-1RA: Glucagon-like peptide-1 receptor agonist; ACEI: Angiotensin-converting enzyme inhibitors; ARBs: Angiotensin II receptor blockers

Back to article page

Cardiovascular Diabetology – Endocrinology Reports

ISSN: 3059-4057

Contact us